Dawnrays Pharmaceutical (Holdings) Limited (HKG:2348)
Hong Kong · Delayed Price · Currency is HKD 1.180
0.00 (0.00%)
At close: Feb 13, 2026
HKG:2348 Revenue
Dawnrays Pharmaceutical (Holdings) had revenue of 630.42M CNY in the half year ending June 30, 2025, a decrease of -3.00%. This brings the company's revenue in the last twelve months to 1.11B, up 3.21% year-over-year. In the year 2024, Dawnrays Pharmaceutical (Holdings) had annual revenue of 1.06B, down -7.89%.
Revenue (ttm)
1.11B CNY
Revenue Growth
+3.21%
P/S Ratio
1.45
Revenue / Employee
997.57K CNY
Employees
1,116
Market Cap
1.77B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.06B | -90.84M | -7.89% |
| Dec 31, 2023 | 1.15B | -126.54M | -9.90% |
| Dec 31, 2022 | 1.28B | 112.53M | 9.66% |
| Dec 31, 2021 | 1.17B | 140.89M | 13.75% |
| Dec 31, 2020 | 1.02B | 74.26M | 7.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition